Immune Checkpoint Inhibitor-Associated Pneumonitis in Non-Small Cell Lung Cancer: Current Understanding in Characteristics, Diagnosis, and Management

Immune Checkpoint Inhibitor-Associated Pneumonitis in Non-Small Cell Lung Cancer: Current Understanding in Characteristics, Diagnosis, and Management

Immunotherapy that includes programmed cell death-1 (PD-1), programmed cell death- ligand 1 (PD-L1) and cytotoxic T lymphocyte antigen 4 (CTLA-4) inhibitors has revolutionized the therapeutic strategy in multiple malignancies. Although it has achieved significant breakthrough in advanced non-small c...

Full description

Bibliographic Details
Main Authors: Qin Zhang, Liansha Tang, Yuwen Zhou, Wenbo He, Weimin Li
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-05-01
Series:Frontiers in Immunology
Subjects:
immune checkpoint inhibitor
pneumonitis
non-small-cell lung cancer
diagnosis
management
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2021.663986/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2021.663986/full

Similar Items